World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
17510
World Ranking
2069
National Ranking
1010

Christian F. Ockenhouse publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Christian F. Ockenhouse sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 189 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Christian F. Ockenhouse D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Christian F. Ockenhouse sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Christian F. Ockenhouse is affiliated with the Walter Reed Army Institute of Research in the United States. Their research activity primarily spans the field of medicine with a focus on public health, environmental and occupational health, infectious diseases, molecular biology, computational theory and mathematics, and general health topics.

The scientist's work centers around several main topics, including:

  • Malaria Research and Control
  • Mosquito-borne diseases and control
  • Computational Drug Discovery Methods
  • Vaccines and immunoinformatics approaches
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • Invertebrate Immune Response Mechanisms

Ockenhouse has authored multiple research papers in a variety of journals and scientific venues. Notable recent papers include:

  • "Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial," 2020, published in Trials
  • "Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention," 2021, published in New England Journal of Medicine
  • "Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial," 2022, published in The Lancet Infectious Diseases
  • "Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial," 2023, published in The Lancet Infectious Diseases
  • "A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults," 2020, published in The Journal of Infectious Diseases

The scientist frequently publishes in venues such as:

  • The Journal of Infectious Diseases
  • The Lancet Infectious Diseases
  • Malaria Journal
  • Zenodo (CERN European Organization for Nuclear Research)
  • Vaccine

Ockenhouse has collaborated extensively with a number of peers, including:

  • Cynthia Lee
  • Opokua Ofori-Anyinam
  • Marc Lievens
  • Erik Jongert
  • Karen Ivinson

Best Publications

  • Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

    Kent E. Kester;James F. Cummings;Opokua Ofori-Anyinam;Christian F. Ockenhouse

  • Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity

    J. E. Epstein;K. Tewari;K. E. Lyke;B. K. L. Sim

  • Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1.

    C. F. Ockenhouse;T. Tegoshi;Y. Maeno;C. Benjamin

  • Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

    Daniel E Neafsey;Michal Juraska;Trevor Bedford;David Benkeser

  • Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor

    Christian F. Ockenhouse;Narendra N. Tandon;Cathleen Magowan;G. A. Jamieson

  • Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction

    James J. Moon;Heikyung Suh;Heikyung Suh;Adrienne Victoria Li;Christian F. Ockenhouse

  • Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.

    Bernhards R. Ogutu;Odika J. Apollo;Denise McKinney;Willis Okoth

  • Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria

    Kent E. Kester;Denise A. McKinney;Nadia Tornieporth;Christian F. Ockenhouse

  • Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis.

    Ramachandra S. Naik;Ora Lee H. Branch;Amina S. Woods;Matam Vijaykumar

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Long-Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

    J A Stoute;K E Kester;U Krzych;B T Wellde

  • Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria

    Jason W. Bennett;Brandon S. Pybus;Anjali Yadava;Donna Tosh

  • Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1.

    C. F. Ockenhouse;May Ho;N. N. Tandon;G. A. Van Seventer

  • Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.

    Ricardo Palacios;Elizabeth González Patiño;Roberta de Oliveira Piorelli;Monica Tilli Reis Pessoa Conde

  • Systems analysis of protective immune responses to RTS,S malaria vaccination in humans

    Dmitri Kazmin;Helder I Nakaya;Eva K Lee;Matthew J Johnson

  • Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta.

    Rajeshwara N. Achur;Manojkumar Valiyaveettil;Abdulnaser Alkhalil;Christian F. Ockenhouse

  • Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

    D. Gray Heppner;Kent E. Kester;Christian F. Ockenhouse;Nadia Tornieporth

  • Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus

    Christian F. Ockenhouse;Rajashekhar Betageri;Timothy A. Springer;Donald E. Staunton

  • Development of a Highly Sensitive Genus-Specific Quantitative Reverse Transcriptase Real-Time PCR Assay for Detection and Quantitation of Plasmodium by Amplifying RNA and DNA of the 18S rRNA Genes

    Edwin Kamau;LaDonna S. Tolbert;Luke Kortepeter;Michael Pratt

  • Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

    Michele D. Spring;James F. Cummings;Christian F. Ockenhouse;Sheetij Dutta

  • Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

    Jason A. Regules;Susan B. Cicatelli;Jason W. Bennett;Kristopher M. Paolino

  • Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy.

    Iona O'Neil-Dunne;Iona O'Neil-Dunne;Rajeshwara N. Achur;Sean T. Agbor-Enoh;Sean T. Agbor-Enoh;Sean T. Agbor-Enoh;Manojkumar Valiyaveettil

Frequent Co-Authors

W. Ripley Ballou
W. Ripley Ballou International AIDS Vaccine Initiative
Kent E. Kester
Kent E. Kester Walter Reed Army Institute of Research
Joe Cohen
Joe Cohen GlaxoSmithKline (United Kingdom)
D. Gray Heppner
D. Gray Heppner Crozet BioPharma
Urszula Krzych
Urszula Krzych United States Army Research Laboratory
David E. Lanar
David E. Lanar Walter Reed Army Institute of Research
Martha Sedegah
Martha Sedegah Naval Medical Research Center
D. Channe Gowda
D. Channe Gowda University of Mysore
Thomas L. Richie
Thomas L. Richie Naval Medical Research Center
Robert W. Sauerwein
Robert W. Sauerwein Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, many healthcare professionals explore advanced degrees such as Psychiatric Nurse Practitioner programs. Finding the best pmhnp programs with strong clinical placement rates is crucial for hands-on experience and career readiness.

Cost is often a significant factor when selecting an online program. Students can discover the most cost-effective options by reviewing resources like the cheapest psych np programs online, which offer quality education without a high financial burden.

Post-graduation, understanding potential earnings is essential. The doctorate in nursing salary varies by location and specialization, informing professionals where their skills are most in demand and lucrative.

Additionally, nurses looking to advance can pursue specialized pathways such as a fnp to acute care np bridge program, enabling a smooth transition into acute care settings and broadening career opportunities.

Best Scientists Citing Christian F. Ockenhouse

Trending Scientists

Recently Published Articles